Tower Research Capital LLC (TRC) - ORIC PHARMACEUTICALS INC ownership

ORIC PHARMACEUTICALS INC's ticker is ORIC and the CUSIP is 68622P109. A total of 93 filers reported holding ORIC PHARMACEUTICALS INC in Q4 2023. The put-call ratio across all filers is 0.86 and the average weighting 0.6%.

Quarter-by-quarter ownership
Tower Research Capital LLC (TRC) ownership history of ORIC PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2024$35,371
+243.0%
5,003
+567.1%
0.00%
Q1 2024$10,312
-87.9%
750
-91.9%
0.00%
-100.0%
Q4 2023$85,146
+81.9%
9,255
+19.6%
0.00%0.0%
Q3 2023$46,814
+186.9%
7,738
+268.0%
0.00%0.0%
Q2 2023$16,319
+30690.6%
2,103
-76.8%
0.00%
-50.0%
Q4 2022$53
-99.8%
9,077
+30.3%
0.00%
Q3 2022$22,000
-60.0%
6,967
-42.4%
0.00%
-100.0%
Q2 2022$55,000
-41.5%
12,093
-31.0%
0.00%0.0%
Q1 2022$94,000
+683.3%
17,530
+2056.2%
0.00%
Q4 2021$12,000
-77.4%
813
-67.6%
0.00%
-100.0%
Q3 2021$53,000
+65.6%
2,510
+34.7%
0.00%0.0%
Q2 2021$32,000
-15.8%
1,863
+20.0%
0.00%0.0%
Q1 2021$38,000
-57.3%
1,552
-41.1%
0.00%
-66.7%
Q4 2020$89,000
-53.9%
2,635
-65.9%
0.00%
+50.0%
Q3 2020$193,000
+1186.7%
7,728
+1664.4%
0.00%
+100.0%
Q2 2020$15,0004380.00%
Other shareholders
ORIC PHARMACEUTICALS INC shareholders Q4 2023
NameSharesValueWeighting ↓
Memorial Sloan Kettering Cancer Center 602,272$4,673,63114.75%
Nextech Invest Ltd. 4,285,714$33,257,14111.30%
Column Group LLC 3,568,181$27,689,08510.75%
Prosight Management, LP 5,522,936$42,857,9846.42%
Invus Financial Advisors, LLC 1,007,575$7,818,7824.18%
SILVERARC CAPITAL MANAGEMENT, LLC 1,450,822$11,258,3793.48%
VR Adviser, LLC 2,142,856$16,628,5632.66%
Euclidean Capital LLC 747,550$5,800,9881.49%
Frazier Life Sciences Management, L.P. 2,142,855$16,628,5550.99%
Monaco Asset Management SAM 378,222$2,935,0030.82%
View complete list of ORIC PHARMACEUTICALS INC shareholders